400 Participants Needed

Rosie Chatbot Assistance for Pregnancy and Infant Care

EM
QC
EM
Overseen ByElizabeth M Aparicio, PhD, MSW, LCSW-C
Age: Any Age
Sex: Female
Trial Phase: Academic
Sponsor: University of Maryland, College Park
No Placebo GroupAll trial participants will receive the active study treatment (no placebo)
Approved in 1 JurisdictionThis treatment is already approved in other countries

What You Need to Know Before You Apply

What is the purpose of this trial?

Rosie the Chatbot is an educational chatbot that moms can have on their computers or cellphones and will work by moms typing in their questions about pregnancy, health, infant milestones, and other variety of health related topics and receiving back a response immediately. Rosie only provides information from verified sources such as children's hospitals, health organizations and government agencies. Rosie does not ask moms to provide any personal information on her or her child, her chat is completely confidential, it works in English and Spanish and will be free.

Do I need to stop my current medications to join the trial?

The trial information does not specify whether you need to stop taking your current medications. It seems focused on using a chatbot for educational purposes, so it's unlikely that medication changes are required.

Is Rosie the Chatbot safe for use in pregnancy and infant care?

There is no specific safety data available for Rosie the Chatbot, but similar chatbots have been used to provide health information without reported safety issues. The development of Rosie involved community input, suggesting a focus on user needs and safety.12345

How is the Rosie Chatbot Assistance for Pregnancy and Infant Care treatment different from other treatments?

The Rosie Chatbot is unique because it provides personalized, easy-to-access health information specifically designed to address maternal and infant health disparities, particularly in communities of color. Unlike traditional treatments, it uses conversational technology to offer real-time support and education, helping to close the racial gap in health outcomes.13567

What data supports the effectiveness of the treatment Rosie the Chatbot for pregnancy and infant care?

Research shows that chatbots like Rosie can be helpful in providing health information to pregnant women and new mothers. In a study, 90% of participants expressed a likelihood to use the Rosie app, indicating a strong interest and potential for improving access to reliable health information.13589

Who Is on the Research Team?

QC

Quynh C Nguyen, PhD

Principal Investigator

University of Maryland

EM

Elizabeth M Aparicio, PhD, LCSW-C

Principal Investigator

University of Maryland

Are You a Good Fit for This Trial?

This trial is for moms or pregnant women who are at least 14 years old, belong to racial/ethnic minority groups, and can read English or Spanish. It's designed for those with an infant under 6 months old or who are currently expecting.

Inclusion Criteria

I am 14 years old or older.
You possess fluency in either English or Spanish.
I am currently pregnant or have a baby under 6 months old.
See 1 more

Timeline for a Trial Participant

Screening

Participants are screened for eligibility to participate in the trial

2-4 weeks

Treatment

Participants are randomly assigned to either the Rosie the Chatbot group or the Book Club group. The Rosie group uses the chatbot app, while the Book Club group receives monthly children's books.

12 months
Pre-test, mid-test, and post-test health surveys

Follow-up

Participants are monitored for maternal and infant health outcomes, including well-baby visits, maternal postpartum depression, and emergency room visits.

12 months post randomization

What Are the Treatments Tested in This Trial?

Interventions

  • Rosie the Chatbot
Trial Overview The trial is testing 'Rosie the Chatbot,' a digital assistant that provides immediate health-related information about pregnancy and infant care from verified sources in both English and Spanish without requiring personal data.
How Is the Trial Designed?
2Treatment groups
Experimental Treatment
Active Control
Group I: Rosie the Chatbot GroupExperimental Treatment1 Intervention
Group II: Book Club GroupActive Control1 Intervention

Find a Clinic Near You

Who Is Running the Clinical Trial?

University of Maryland, College Park

Lead Sponsor

Trials
163
Recruited
46,800+

National Institutes of Health (NIH)

Collaborator

Trials
2,896
Recruited
8,053,000+

National Institute on Minority Health and Health Disparities (NIMHD)

Collaborator

Trials
473
Recruited
1,374,000+

Published Research Related to This Trial

The study highlights the potential of chatbots as effective digital health tools for improving self-care among pregnant women, which is crucial for managing health outcomes during pregnancy.
A systematic literature review revealed limited existing research on user experiences with chatbots in this context, indicating a need for further exploration and development of such technologies in primary health care services in Brazil.
GISSA intelligent chatbot experience - How effective was the interaction between pregnant women and a chatbot during the COVID-19 pandemic?Silveira, R., Pernencar, C., de Sousa, F., et al.[2023]
The online preconception conversational agent 'Gabby' significantly reduced the number and proportion of preconception health risks among 100 African American women, with the Gabby group showing an average reduction of 8.3 risks compared to 5.5 in the control group over six months.
Participants in the Gabby group found the system easy to use, with 64% reporting they used the information to improve their health, indicating that Gabby may be an effective tool for addressing health disparities in preconception care.
Reducing Preconception Risks Among African American Women with Conversational Agent Technology.Jack, B., Bickmore, T., Hempstead, M., et al.[2022]
The chatbot Rosie is being developed to provide accessible and reliable health information to pregnant women and new mothers of color, addressing the higher maternal and infant mortality rates in these communities.
During demonstrations with 109 participants, 90% expressed a likelihood to use Rosie, indicating a strong demand for resources that support maternal and infant health, particularly in areas like baby development and nutrition.
Practical Guidance for the Development of Rosie, a Health Education Question-and-Answer Chatbot for New Mothers.Mane, HY., Channell Doig, A., Marin Gutierrez, FX., et al.[2023]

Citations

GISSA intelligent chatbot experience - How effective was the interaction between pregnant women and a chatbot during the COVID-19 pandemic? [2023]
Reducing Preconception Risks Among African American Women with Conversational Agent Technology. [2022]
Practical Guidance for the Development of Rosie, a Health Education Question-and-Answer Chatbot for New Mothers. [2023]
Health-focused conversational agents in person-centered care: a review of apps. [2022]
The Perspectives of Women and Their Health-Care Providers Regarding Using an ECA to Support Mode of Birth Decisions. [2022]
Mitigating Patient and Consumer Safety Risks When Using Conversational Assistants for Medical Information: Exploratory Mixed Methods Experiment. [2022]
Patient and Consumer Safety Risks When Using Conversational Assistants for Medical Information: An Observational Study of Siri, Alexa, and Google Assistant. [2019]
Insights of Parents and Parents-To-Be in Using Chatbots to Improve Their Preconception, Pregnancy, and Postpartum Health: A Mixed Studies Review. [2023]
'Parentbot - A Digital healthcare Assistant (PDA)': A mobile application-based perinatal intervention for parents: Development study. [2023]
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Terms of Service·Privacy Policy·Cookies·Security